IRIS
FORNARO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.454
EU - Europa 1.589
AS - Asia 1.485
SA - Sud America 359
Continente sconosciuto - Info sul continente non disponibili 232
AF - Africa 92
OC - Oceania 4
Totale 6.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.365
SG - Singapore 678
IT - Italia 574
BR - Brasile 272
DE - Germania 224
CN - Cina 219
RU - Federazione Russa 196
FI - Finlandia 157
HK - Hong Kong 143
SE - Svezia 137
VN - Vietnam 110
FR - Francia 108
GB - Regno Unito 68
BD - Bangladesh 64
IN - India 59
CA - Canada 55
AR - Argentina 38
JP - Giappone 33
ZA - Sudafrica 31
CI - Costa d'Avorio 27
IQ - Iraq 25
PL - Polonia 23
ID - Indonesia 22
TR - Turchia 22
NL - Olanda 21
MX - Messico 20
PK - Pakistan 18
EC - Ecuador 16
SA - Arabia Saudita 15
BE - Belgio 14
AT - Austria 13
PH - Filippine 13
VE - Venezuela 10
LT - Lituania 9
CO - Colombia 8
UA - Ucraina 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
ES - Italia 7
IR - Iran 7
JM - Giamaica 7
MY - Malesia 7
AM - Armenia 6
CL - Cile 6
KE - Kenya 6
MA - Marocco 6
TN - Tunisia 6
KZ - Kazakistan 5
PY - Paraguay 5
AU - Australia 4
CH - Svizzera 4
AE - Emirati Arabi Uniti 3
CG - Congo 3
ET - Etiopia 3
IL - Israele 3
KG - Kirghizistan 3
LB - Libano 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
EE - Estonia 2
EG - Egitto 2
IE - Irlanda 2
KR - Corea 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CM - Camerun 1
DK - Danimarca 1
GF - Guiana Francese 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
MK - Macedonia 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TL - Timor Orientale 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.983
Salva come PNG Salva come JPEG
Città #
Singapore 391
Ashburn 368
San Jose 216
Chandler 170
Milan 168
Hong Kong 143
Munich 138
Helsinki 120
Fairfield 115
Nyköping 114
Beijing 101
Council Bluffs 91
Los Angeles 69
Dallas 65
New York 63
Houston 58
Lauterbourg 53
Cambridge 50
Rome 50
Bari 44
Woodbridge 43
Moscow 41
Seattle 41
Columbus 36
Wilmington 36
Ho Chi Minh City 34
Falkenstein 33
São Paulo 32
Santa Clara 31
Ann Arbor 28
Abidjan 27
Boardman 27
Hanoi 27
Lawrence 26
Figino 25
Buffalo 22
Turku 22
Warsaw 20
Tokyo 19
Inglewood 18
Roxbury 18
Chicago 17
Frankfurt am Main 17
Johannesburg 17
Montreal 16
London 15
Toronto 15
Brussels 14
Des Moines 13
Brooklyn 12
Denver 12
Phoenix 12
Poplar 12
San Francisco 12
El Paso 11
Jakarta 11
Florence 10
Naples 10
Stockholm 10
Manchester 9
Mexico City 9
Orem 9
Paris 9
Princeton 9
Amsterdam 8
Bacolod City 8
Baghdad 8
Boston 8
Dhaka 8
Jyväskylä 8
Mumbai 8
Pescara 8
Atlanta 7
Chennai 7
Pittsburgh 7
Quito 7
Rio de Janeiro 7
Riyadh 7
Turin 7
Ankara 6
Bengaluru 6
Nuremberg 6
Queens 6
Redwood City 6
Salt Lake City 6
Shanghai 6
Tashkent 6
Yerevan 6
Belo Horizonte 5
Brasília 5
Da Nang 5
Düsseldorf 5
Haiphong 5
Illkirch-Graffenstaden 5
Lahore 5
Modugno 5
Nairobi 5
Ottawa 5
Porto Alegre 5
Pune 5
Totale 3.701
Salva come PNG Salva come JPEG
Nome #
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 233
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 200
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 190
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 190
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 181
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 178
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 172
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 169
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 150
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 148
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 134
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 130
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 124
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 123
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 121
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 120
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 115
Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi) 114
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 109
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study 109
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 106
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 105
Cartilage damage: clinical approach 105
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 102
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 102
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis 101
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 99
Complete Hydatidiform Mole Mimicking Sacroiliitis 98
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 97
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 96
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 94
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 92
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 92
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 90
Effectiveness of Tapering Rituximab Dose in Idiopathic Inflammatory Myopathies: Real-World Data from a Monocentric Study 90
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 88
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 87
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 80
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 75
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 73
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 72
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry 72
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 71
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 70
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry 70
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 70
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 69
The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis 68
Letters to the editors 68
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 64
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 64
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 57
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies 56
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 52
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 39
Predictors of long-term clinical remission in rheumatoid arthritis 39
Mobile session fixation attack in micropayment systems 36
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry 32
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study 31
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study 30
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity 29
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors 27
Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies 27
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 26
Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers 25
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al‘ by Agca et al 24
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE) 23
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 10
Sjögren’s disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessment 6
Immune-mediated necrotizing myopathies: clinico-serological features and treatment outcomes of a large Italian cohort of patients 3
Dermatomyositis is characterized by TYK2-dependent STAT3 activation 3
Totale 6.215
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.422
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022215 0 0 5 10 9 11 25 14 17 30 32 62
2022/2023455 46 76 30 31 30 69 9 66 61 6 19 12
2023/2024221 17 45 13 19 13 41 9 6 3 7 3 45
2024/20251.364 42 13 62 26 25 136 188 247 65 95 174 291
2025/20263.123 388 151 218 350 415 170 284 105 304 307 106 325
2026/2027352 127 133 92 0 0 0 0 0 0 0 0 0
Totale 6.215